Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine

References

• HanRZhuJYangXXuHSurface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cellsJ Biomed Mater Res A201196114214921105162
   PubMed Web of Science ®Google Scholar
• RoyASinghMSUpadhyayPBhaskarSNanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse modelInt J Pharm20134451–217118023376226
   PubMed Web of Science ®Google Scholar
• HamdySHaddadiAHungRWLavasanifarATargeting dendritic cells with nano-particulate PLGA cancer vaccine formulationsAdv Drug Deliv Rev20116310–1194395521679733
   PubMed Web of Science ®Google Scholar
• KalinskiPEdingtonHZehHJDendritic cells in cancer immunotherapy: vaccines or autologous transplants?Immunol Res2011502–323524721717071
   PubMed Web of Science ®Google Scholar
• Sanchez-RuizYValituttiSDupreLStepwise maturation of lytic granules during differentiation and activation of human CD8+ T lymphocytesPLoS One2011611e2705722073254
   PubMed Web of Science ®Google Scholar
• WhitesideTLImmune responses to malignanciesJ Allergy Clin Immunol20101252 Suppl 2S272S28320061007
   PubMed Web of Science ®Google Scholar
• MamedovIZBritanovaOVZvyaginIVPreparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profilingFront Immunol2013445624391640
   PubMed Web of Science ®Google Scholar
• ButterfieldLHDendritic cells in cancer immunotherapy clinical trials: are we making progress?Front Immunol2013445424379816
   PubMed Web of Science ®Google Scholar
• XuHCaoXDendritic cell vaccines in cancer immunotherapy: from biology to translational medicineFront Med20115432333222198743
   PubMedGoogle Scholar
• BonifazLBonnyayDMahnkeKRiveraMNussenzweigMCSteinmanRMEfficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell toleranceJ Exp Med2002196121627163812486105
   PubMed Web of Science ®Google Scholar
• YanofskyVRMitsuiHFelsenDCarucciJAUnderstanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapyClin Dev Immunol2013201362412323606870
   PubMedGoogle Scholar
• De Souza ReboucasJEsparzaIFerrerMSanzMLIracheJMGamazoCNanoparticulate adjuvants and delivery systems for allergen immunotherapyJ Biomed Biotechnol2012201247460522496608
   PubMedGoogle Scholar
• DementoSSteenblockERFahmyTMBiomimetic approaches to modulating the T cell immune response with nano- and micro-particlesConf Proc IEEE Eng Med Biol Soc200920091161116619963488
   PubMedGoogle Scholar
• HamdySMolaviOMaZCo-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunityVaccine200826395046505718680779
   PubMed Web of Science ®Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPreatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
   PubMed Web of Science ®Google Scholar
• SilvaALRosaliaRASazakAOptimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activationEur J Pharm Biopharm201383333834523201055
   PubMed Web of Science ®Google Scholar
• HanFYThurechtKJWhittakerAKSmithMTBioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loadingFront Pharmacol2016718527445821
   PubMed Web of Science ®Google Scholar
• Rice-FichtACArenas-GamboaAMKahl-McDonaghMMFichtTAPolymeric particles in vaccine deliveryCurr Opin Microbiol201013110611220079678
   PubMed Web of Science ®Google Scholar
• DiwanMElamanchiliPLaneHGainerASamuelJBiodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responsesJ Drug Target2003118–1049550715203918
   PubMed Web of Science ®Google Scholar
• RaghuwanshiDMishraVSureshMRKaurKA simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticlesVaccine201230507292729923022399
   PubMed Web of Science ®Google Scholar
• DhodapkarMVSznolMZhaoBInduction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Sci Transl Med20146232232ra251
   Web of Science ®Google Scholar
• WaltersAASomavarapuSRiithoVAssessment of the enhancement of PLGA nanoparticle uptake by dendritic cells through the addition of natural receptor ligands and monoclonal antibodyVaccine201533486588659526529067
   PubMed Web of Science ®Google Scholar
• SolbrigCMSaucier-SawyerJKCodyVSaltzmanWMHanlonDJPolymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cellsMol Pharm200741475717217312
   PubMedGoogle Scholar
• JahanSTHaddadiAInvestigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticlesInt J Nanomedicine2015107371738426677326
   PubMed Web of Science ®Google Scholar
• CorriganOILiXQuantifying drug release from PLGA nanoparticulatesEur J Pharm Sci2009373–447748519379812
   PubMed Web of Science ®Google Scholar
• ThamakeSIRautSLRanjanAPGryczynskiZVishwanathaJKSurface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapyNanotechnology201122303510121149963
   PubMed Web of Science ®Google Scholar
• KocbekPObermajerNCegnarMKosJKristlJTargeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJ Control Release20071201–2182617509712
   PubMed Web of Science ®Google Scholar
• YuZGWangQLiKLiYQGaoXXDetermination and pharmacokinetics of 6,7-dimethoxycoumarin in rat plasma after intra-gastric administration of different decoctions of yinchenhao tangJ Chromatogr Sci200745854454818019567
   PubMed Web of Science ®Google Scholar
• HaddadiAElamanchiliPLavasanifarADasSShapiroJSamuelJDelivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cellsJ Biomed Mater Res A200884488589817647224
   PubMedGoogle Scholar
• HamdySHaddadiAShayeganpourASamuelJLavasanifarAActivation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticlesPharm Res20112892288230121560020
   PubMed Web of Science ®Google Scholar
• BandyopadhyayAFineRLDementoSBockenstedtLKFahmyTMThe impact of nanoparticle ligand density on dendritic-cell targeted vaccinesBiomaterials201132113094310521262534
   PubMed Web of Science ®Google Scholar
• ChenHGaoJLuYPreparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapyJ Control Release2008128320921618450313
   PubMed Web of Science ®Google Scholar
• GhotbiZHaddadiAHamdySHungRWSamuelJLavasanifarAActive targeting of dendritic cells with mannan-decorated PLGA nanoparticlesJ Drug Target201119428129220590403
   PubMed Web of Science ®Google Scholar
• HeoMBLimYTProgrammed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cellsBiomaterials201435159060024125775
   PubMed Web of Science ®Google Scholar
• SartiFPereraGHintzenFIn vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid ABiomaterials201132164052405721377204
   PubMed Web of Science ®Google Scholar
• ZhuLChenLCaoQRChenDCuiJPreparation and evaluation of mannose receptor mediated macrophage targeting delivery systemJ Control Release2011152Suppl 1e190e19122195844
   PubMedGoogle Scholar
• HaddadiAHamdySGhotbiZSamuelJLavasanifarAImmuno-adjuvant activity of the nanoparticles’ surface modified with mannanNanotechnology2014253535510125119543
   PubMed Web of Science ®Google Scholar
• HeoMBChoMYLimYTPolymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cellsActa Biomater20141052169217624394635
   PubMed Web of Science ®Google Scholar
• HamdySHaddadiASomayajiVRuanDSamuelJPharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (D,L-lactic-co-glycolic acid) nanoparticle formulationsJ Pharm Biomed Anal200744491492317590559
   PubMed Web of Science ®Google Scholar
• BaoXGaoMXuHA novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatmentDrug Dev Ind Pharm20154171193120325026246
   PubMed Web of Science ®Google Scholar
• WinKYFengSSEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials200526152713272215585275
   PubMed Web of Science ®Google Scholar
• CruzLJTackenPJFokkinkRFigdorCGThe influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cellsBiomaterials201132286791680321724247
   PubMed Web of Science ®Google Scholar
• DinarvandRSepehriNManoochehriSRouhaniHAtyabiFPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agentsInt J Nanomedicine2011687789521720501
   PubMed Web of Science ®Google Scholar
• MakadiaHKSiegelSJPoly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrierPolymers2011331377139722577513
   PubMed Web of Science ®Google Scholar
• SlutterBBalSKeijzerCNasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigenVaccine201028386282629120638455
   PubMed Web of Science ®Google Scholar
• KumarAWongananPSandovalMALiXZhuSCuiZMicroneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticlesJ Control Release2012163223023922921518
   PubMed Web of Science ®Google Scholar
• MukherjeeBSantraKPattnaikGGhoshSPreparation, characterization and in vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymersInt J Nanomedicine20083448749619337417
   PubMed Web of Science ®Google Scholar
• WuFJinTPolymer-based sustained-release dosage forms for protein drugs, challenges, and recent advancesAAPS PharmSciTech2008941218122919085110
   PubMed Web of Science ®Google Scholar
• AlshamsanAHaddadiAHamdySSTAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune responseMol Pharm2010751643165420804176
   PubMedGoogle Scholar
• KakaASFosterAEWeissHLRooneyCMLeenAMUsing dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary taleJ Immunother200831435936918391760
   PubMed Web of Science ®Google Scholar
• KrishnamachariYGearySMLemkeCDSalemAKNanoparticle delivery systems in cancer vaccinesPharm Res201128221523620721603
   PubMed Web of Science ®Google Scholar
• LangenkampAMessiMLanzavecchiaASallustoFKinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cellsNat Immunol20001431131611017102
   PubMed Web of Science ®Google Scholar
• DementoSLBonafeNCuiWTLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitisJ Immunol201018552989299720660705
   PubMed Web of Science ®Google Scholar
• MahnkeKSchmittEBonifazLEnkAHJonuleitHImmature, but not inactive: the tolerogenic function of immature dendritic cellsImmunol Cell Biol200280547748312225384
   PubMed Web of Science ®Google Scholar